December 22, 2017 / 3:26 AM / 10 months ago

BRIEF-Zhejiang Medicine terminates clinical trial for a kind of antitumor drug

Dec 22 (Reuters) - Zhejiang Medicine Co Ltd :

* Says it decided to terminate clinical trials for a kind of antitumor drug (R&D code name of XC302)

Source text in Chinese: goo.gl/MTcbAZ

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below